Home › NCT07561827
The Effect of Erector Spinae Plane Block (ESPB) on Pediatric Pain Management Following Posterior Spinal Fusion (PSF) Surgery
Who can join
Ages 10 to 18 · All sexes
Full eligibility criteria
Inclusion Criteria: * Diagnosis of Adolescent Idiopathic Scoliosis (AIS) or neuromuscular scoliosis * Undergoing Posterior Spinal Fusion (PSF) Surgery Exclusion Criteria: * Patients with forms of scoliosis other than AIS or NM Scoliosis. * Patients undergoing a spinal deformity correction surgery other than Posterior Spinal Fusion Surgery * Allergy or other contraindication to erector spinae plane block (ESPB) with Ropivacaine patients who are taking pre-operative opioids
About the study
This study is being done to better understand the efficacy of an erector spinae plane block (ESPB) in pain management for children with Adolescent Idiopathic Scoliosis or Neuromuscular Scoliosis undergoing Posterior Spinal Fusion surgery. The study team is trying to find out if receiving the ESPB leads to less pain and less need for pain medication after surgery.
The ESPB involves an injection of a local anesthetic, ropivacaine, into your child's back muscles to help block pain signals.
What is being tested
- Ropivacaine Hydrocloride (drug)
Sponsor: University of California, San Francisco · Participants: 42 · Started: Jun 6, 2025
Contact the study team
- Tripta Rughwani · Phone: 415-353-4701
- Stephanie Chu · Phone: 415-353-1454
Official record on ClinicalTrials.gov — NCT07561827
Locations in the U.S.
| California | University of California San Francisco, San Francisco |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.